3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Skin Neoplasms
2
Myelodysplastic Syndromes
2
Prostatic Neoplasms
1
Neoplasms
1
Myofibroma
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Intraocular Lymphoma
1
Inflammation
1
Hemorrhage
1
Eye Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cytopenia
1
Corneal Endothelial Cell Loss
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Cataract
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenomyosis
1
Interventions
Radiosurgery
45
Magnetic Resonance Spectroscopy
41
Standard of Care
27
Radiotherapy
27
Exercise
27
Brachytherapy
21
Early Intervention, Educational
20
Surveys and Questionnaires
18
Multiparametric Magnetic Resonance Imaging
17
Magnetic Resonance Imaging
16
Androgen Antagonists
16
Blood Specimen Collection
15
Interviews as Topic
14
Radiotherapy, Intensity-Modulated
13
Methods
13
Therapeutics
12
Psychiatric Rehabilitation
12
Educational Status
12
Biopsy
12
Specimen Handling
10
Resistance Training
10
Prostatectomy
9
Diet Therapy
9
Counseling
9
gallium 68 PSMA-11
8
Radiation
8
Proton Therapy
8
Practice Guidelines as Topic
8
High-Intensity Interval Training
7
Electroporation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Prostatic Neoplasms
×
Ascorbic Acid
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled